Sylvain Dukic

517 total citations
20 papers, 420 citations indexed

About

Sylvain Dukic is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Sylvain Dukic has authored 20 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Molecular Biology. Recurrent topics in Sylvain Dukic's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (3 papers). Sylvain Dukic is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (3 papers). Sylvain Dukic collaborates with scholars based in France and Austria. Sylvain Dukic's co-authors include A. Beljebbar, Richard Vistelle, Michel Manfait, M Pluot, Lydie Ventéo, Matthieu L. Kaltenbach, Guillaume Hoizey, Michaël Molinari, Laurence Van Gulick and Gaëlle Roullin and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Sylvain Dukic

20 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvain Dukic France 11 181 122 121 78 57 20 420
Hongtao Chen China 13 138 0.8× 267 2.2× 62 0.5× 89 1.1× 25 0.4× 20 542
Christoph Pohling United States 11 121 0.7× 115 0.9× 62 0.5× 128 1.6× 37 0.6× 17 395
Austin J. Moy United States 12 177 1.0× 97 0.8× 94 0.8× 261 3.3× 77 1.4× 23 485
Lily H. Laiho United States 6 233 1.3× 121 1.0× 10 0.1× 211 2.7× 60 1.1× 11 577
Vitor B. Pelegati Brazil 13 143 0.8× 99 0.8× 9 0.1× 143 1.8× 27 0.5× 32 403
Han-Wei Wang China 12 272 1.5× 148 1.2× 103 0.9× 125 1.6× 31 0.5× 16 531
Amy T. Shah United States 10 121 0.7× 160 1.3× 7 0.1× 167 2.1× 82 1.4× 13 437
Nagako Kawashima Japan 11 43 0.2× 320 2.6× 13 0.1× 64 0.8× 28 0.5× 20 484
Ahmad Golaraei Canada 10 227 1.3× 107 0.9× 16 0.1× 149 1.9× 32 0.6× 16 365

Countries citing papers authored by Sylvain Dukic

Since Specialization
Citations

This map shows the geographic impact of Sylvain Dukic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Dukic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Dukic more than expected).

Fields of papers citing papers by Sylvain Dukic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Dukic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Dukic. The network helps show where Sylvain Dukic may publish in the future.

Co-authorship network of co-authors of Sylvain Dukic

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Dukic. A scholar is included among the top collaborators of Sylvain Dukic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Dukic. Sylvain Dukic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Slimano, Florian, Amélie Cransac, Pascal Foucher, et al.. (2022). Association between proton pump inhibitors and severe hematological toxicity in patients receiving pemetrexed-based anticancer treatment: The prospective IPPEM study. Lung Cancer. 166. 114–121. 4 indexed citations
2.
Slimano, Florian, et al.. (2019). Intratumoral distribution of YSNSG cyclopeptide in a mouse melanoma model using microdialysis. European Journal of Pharmaceutical Sciences. 143. 105201–105201. 2 indexed citations
3.
Ramont, Laurent, Bertrand Brassart, Sylvain Dukic, et al.. (2018). Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition. Scientific Reports. 8(1). 9837–9837. 22 indexed citations
4.
Lameiras, Pédro, A. Beljebbar, Alexandre Berquand, et al.. (2018). Structural characterization andin vivopro-tumor properties of a highly conserved matrikine. Oncotarget. 9(25). 17839–17857. 21 indexed citations
5.
Slimano, Florian, et al.. (2017). First plasma and tissue pharmacokinetic study of the YSNSG cyclopeptide, a new integrin antagonist, using microdialysis. European Journal of Pharmaceutical Sciences. 105. 178–187. 2 indexed citations
6.
Roullin, Gaëlle, Juliette Moreau, Laurence Van Gulick, et al.. (2014). Encapsulated Ruthenium(II) Complexes in Biocompatible Poly(d,l‐lactide‐co‐glycolide) Nanoparticles for Application in Photodynamic Therapy. ChemPlusChem. 79(1). 171–180. 42 indexed citations
7.
Djerada, Zoubir, et al.. (2013). Extracellular NAADP affords cardioprotection against ischemia and reperfusion injury and involves the P2Y11-like receptor. Biochemical and Biophysical Research Communications. 434(3). 428–433. 23 indexed citations
8.
Callewaert, Maïté, et al.. (2012). Etoposide encapsulation in surface‐modified poly(lactide‐co‐glycolide) nanoparticles strongly enhances glioma antitumor efficiency. Journal of Biomedical Materials Research Part A. 101A(5). 1319–1327. 31 indexed citations
9.
Beljebbar, A., et al.. (2010). Ex vivo and in vivo diagnosis of C6 glioblastoma development by Raman spectroscopy coupled to a microprobe. Analytical and Bioanalytical Chemistry. 398(1). 477–487. 66 indexed citations
10.
Beljebbar, A., et al.. (2007). Discriminating healthy from tumor and necrosis tissue in rat brain tissue samples by Raman spectral imaging. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(10). 2605–2615. 79 indexed citations
11.
Beljebbar, A., Sylvain Dukic, Lydie Ventéo, et al.. (2006). Brain tissue characterisation by infrared imaging in a rat glioma model. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1758(7). 892–899. 51 indexed citations
12.
Angiboust, Jean‐François, Wenqiang Qiao, Ganesh D. Sockalingum, et al.. (2004). Shear force near‐field optical microscope based on Q‐controlled bimorph sensor for biological imaging in liquid. Journal of Microscopy. 216(3). 229–233. 3 indexed citations
13.
Dukic, Sylvain, Matthieu L. Kaltenbach, Tony Heurtaux, et al.. (2004). Influence of C6 and CNS1 Brain Tumors on Methotrexate Pharmacokinetics in Plasma and Brain Tissue. Journal of Neuro-Oncology. 67(1-2). 131–138. 9 indexed citations
14.
Hoizey, Guillaume, Matthieu L. Kaltenbach, Sylvain Dukic, et al.. (2001). Pharmacokinetics of gacyclidine enantiomers in plasma and spinal cord after single enantiomer administration in rats. International Journal of Pharmaceutics. 229(1-2). 147–153. 5 indexed citations
15.
Hoizey, Guillaume, Matthieu L. Kaltenbach, Sylvain Dukic, et al.. (2001). Distribution of Gacyclidine Enantiomers after Experimental Spinal Cord Injury in Rats: Possible Involvement of an Active Transport System. Journal of Pharmaceutical Sciences. 90(1). 70–78. 2 indexed citations
16.
Dukic, Sylvain, Tony Heurtaux, Matthieu L. Kaltenbach, et al.. (2000). Influence of schedule of administration on methotrexate penetration in brain tumours. European Journal of Cancer. 36(12). 1578–1584. 20 indexed citations
17.
Hoizey, Guillaume, Matthieu L. Kaltenbach, Sylvain Dukic, et al.. (2000). Distribution of Gacyclidine Enantiomers in Spinal Cord Extracellular Fluid. Pharmaceutical Research. 17(2). 148–153. 6 indexed citations
18.
Dukic, Sylvain, Tony Heurtaux, Matthieu L. Kaltenbach, et al.. (1999). Pharmacokinetics of Methotrexate in the Extracellular Fluid of Brain C6-Glioma After Intravenous Infusion in Rats. Pharmaceutical Research. 16(8). 1219–1225. 18 indexed citations
19.
Hoizey, Guillaume, et al.. (1999). Sensitive gas chromatographic–mass spectrometric method for the determination of gacyclidine in rat plasma and spinal cord dialyzates. The Analyst. 124(12). 1761–1764. 1 indexed citations
20.
Dukic, Sylvain, et al.. (1998). Determination of free extracellular levels of methotrexate by microdialysis in muscle and solid tumor of the rabbit.. Pharmaceutical Research. 15(1). 133–138. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongtao Chen Breakdown of academic impact, for papers by Christoph Pohling Breakdown of academic impact, for papers by Austin J. Moy Breakdown of academic impact, for papers by Lily H. Laiho Breakdown of academic impact, for papers by Vitor B. Pelegati Breakdown of academic impact, for papers by Han-Wei Wang Breakdown of academic impact, for papers by Amy T. Shah Breakdown of academic impact, for papers by Nagako Kawashima Breakdown of academic impact, for papers by Ahmad Golaraei
Rankless by CCL
2026